Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hans Nijman | M | - |
ViciniVax BV
 ViciniVax BV Pharmaceuticals: OtherHealth Technology ViciniVax BV develops, commercializes, and markets vaccines for the treatment of cancer. It also develops therapies for cervical cancer. The company was founded by Toos Daemen, Hans Nijman, Alfred N. Nijkerk, Ate van der Zee, and Jan C. Wilschut in 2008 and is headquartered in Groningen, Netherlands.
University of Groningen
| 16 years |
| Cees Griffioen | M | 83 |
University of Groningen
| - |
| Stef G. Kranendijk | M | - |
University of Groningen
| - |
| Robert A. H. van der Meer | M | 75 |
University of Groningen
| 35 years |
| Henk A.T. Chin-Sue | M | 71 |
University of Groningen
| - |
| Klaas Poelstra | M | 60 |
University of Groningen
| - |
| Marnix Pool | M | - |
University of Groningen
| - |
| Janneke Meulenberg | M | - |
ViciniVax BV
ViciniVax BV Pharmaceuticals: OtherHealth Technology ViciniVax BV develops, commercializes, and markets vaccines for the treatment of cancer. It also develops therapies for cervical cancer. The company was founded by Toos Daemen, Hans Nijman, Alfred N. Nijkerk, Ate van der Zee, and Jan C. Wilschut in 2008 and is headquartered in Groningen, Netherlands. | - |
| Christopher Hillyer | M | - |
University of Groningen
| 12 years |
| Jacques Wallage | M | 78 |
University of Groningen
| - |
| Wietze Reehoorn | M | 62 |
University of Groningen
| - |
| J. G. van der Linde | F | 67 |
University of Groningen
| - |
| J. M. L. van Engelen | M | 64 |
University of Groningen
| - |
| Hélène Vletter-van Dort | M | 58 |
University of Groningen
| - |
| Ate van der Zee | M | - |
ViciniVax BV
ViciniVax BV Pharmaceuticals: OtherHealth Technology ViciniVax BV develops, commercializes, and markets vaccines for the treatment of cancer. It also develops therapies for cervical cancer. The company was founded by Toos Daemen, Hans Nijman, Alfred N. Nijkerk, Ate van der Zee, and Jan C. Wilschut in 2008 and is headquartered in Groningen, Netherlands. | 16 years |
| Femke de Vries | F | 51 |
University of Groningen
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Alfred N. Nijkerk | M | 59 |
ViciniVax BV
ViciniVax BV Pharmaceuticals: OtherHealth Technology ViciniVax BV develops, commercializes, and markets vaccines for the treatment of cancer. It also develops therapies for cervical cancer. The company was founded by Toos Daemen, Hans Nijman, Alfred N. Nijkerk, Ate van der Zee, and Jan C. Wilschut in 2008 and is headquartered in Groningen, Netherlands. | - |
| Jan C. Wilschut | M | - |
ViciniVax BV
ViciniVax BV Pharmaceuticals: OtherHealth Technology ViciniVax BV develops, commercializes, and markets vaccines for the treatment of cancer. It also develops therapies for cervical cancer. The company was founded by Toos Daemen, Hans Nijman, Alfred N. Nijkerk, Ate van der Zee, and Jan C. Wilschut in 2008 and is headquartered in Groningen, Netherlands. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Netherlands | 18 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Toos Daemen
- Personal Network
